Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells Article

Fuse, Marisa A, Plati, Stephani Klingeman, Burns, Sarah S et al. (2017). Combination Therapy with c-Met and Src Inhibitors Induces Caspase-Dependent Apoptosis of Merlin-Deficient Schwann Cells and Suppresses Growth of Schwannoma Cells . MOLECULAR CANCER THERAPEUTICS, 16(11), 2387-2398. 10.1158/1535-7163.MCT-17-0417

Open Access

cited authors

  • Fuse, Marisa A; Plati, Stephani Klingeman; Burns, Sarah S; Dinh, Christine T; Bracho, Olena; Yan, Denise; Mittal, Rahul; Shen, Rulong; Soulakova, Julia N; Copik, Alicja J; Liu, Xue Zhong; Telischi, Fred F; Chang, Long-Sheng; Franco, Maria Clara; Fernandez-Valle, Cristina

sustainable development goals

authors

publication date

  • November 1, 2017

published in

keywords

  • CABOZANTINIB XL184
  • CANCER
  • GENE
  • Life Sciences & Biomedicine
  • NEUROFIBROMATOSIS TYPE-2
  • Oncology
  • PATHWAY
  • PHASE-II
  • SRC/ABL KINASE INHIBITOR
  • Science & Technology
  • TARGET
  • TUMOR-SUPPRESSOR
  • VESTIBULAR SCHWANNOMAS

Digital Object Identifier (DOI)

publisher

  • AMER ASSOC CANCER RESEARCH

start page

  • 2387

end page

  • 2398

volume

  • 16

issue

  • 11